Techno Medica Co., Ltd.

TSE:6678.T

1783 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 10,283.8519,367.5869,699.0779,040.1159,810.5349,332.428,654.2478,457.2389,032.4229,519.649,000.068,151.1947,980.9337,559.4557,055.1866,730.9466,668.551
Cost of Revenue 5,180.8194,737.2924,881.7964,585.6755,312.054,977.7914,651.5254,337.545,022.6934,990.6984,467.2513,953.6373,912.3463,766.1273,876.1023,464.1513,415.337
Gross Profit 5,103.0324,630.2944,817.2814,454.444,498.4844,354.6294,002.7224,119.6984,009.7294,528.9424,532.8094,197.5574,068.5873,793.3283,179.0843,266.7953,253.214
Gross Profit Ratio 0.4960.4940.4970.4930.4590.4670.4630.4870.4440.4760.5040.5150.510.5020.4510.4850.488
Reseach & Development Expenses 516.25369405433676559446.15657.257464.92834047244600000
General & Administrative Expenses 8785858385862,511.087711311312313000000
Selling & Marketing Expenses 16816419117619919717315814515712813100000
SG&A 2,746.5462,5732,5412,3822,5322,2592,511.082,029.4541,889.0281,8811,8411,74300000
Other Expenses 27.22717.0965.51215.44710.66216.298-2.343-21.1513.1162.4893.0373.683.1232.8632.0091.2541.576
Operating Expenses 3,262.7962,980.8412,955.4132,846.6483,240.7292,836.8362,511.082,701.0142,368.7732,208.6712,376.7962,257.2052,239.7912,342.011,908.2341,883.8761,879.057
Operating Income 1,840.2361,649.4531,861.8681,607.7911,257.7531,517.7921,491.6411,418.6831,640.9552,320.272,156.0121,940.3511,828.7951,451.3181,270.8481,382.9191,374.156
Operating Income Ratio 0.1790.1760.1920.1780.1280.1630.1720.1680.1820.2440.240.2380.2290.1920.180.2050.206
Total Other Income Expenses Net 20.3831613418031179.15-811.333162.0893.0013.5274.4282.4552.2423.7864.94636.35
Income Before Tax 1,860.6191,665.7731,851.0581,649.3141,339.011,549.5831,670.791607.3511,803.0452,323.2722,159.541,944.781,831.2511,453.561,274.6361,387.8651,410.507
Income Before Tax Ratio 0.1810.1780.1910.1820.1360.1660.1930.0720.20.2440.240.2390.2290.1920.1810.2060.212
Income Tax Expense 512.488515.04569.673496.054338.558451.483362.274149.223606.009836.739804.475701.035756.833520.034490.559541.653537.274
Net Income 1,348.131,150.7331,281.3841,153.261,000.4521,098.11,308.516458.1281,197.0351,486.5331,355.0641,243.7451,074.418933.526784.077846.212873.233
Net Income Ratio 0.1310.1230.1320.1280.1020.1180.1510.0540.1330.1560.1510.1530.1350.1230.1110.1260.131
EPS 172.95136.35150.85135.78117.84128.13152.0453.21136.78163.14154.69141.98122.65106.5789.5196.699.68
EPS Diluted 172.95136.35150.85135.78117.84128.13152.0453.21136.78163.14154.69141.98122.65106.5789.5196.699.68
EBITDA 1,953.2181,760.0352,008.5561,709.2811,282.5071,606.2951,562.121,468.9011,720.3752,414.3742,214.9581,986.6081,871.9161,500.9541,315.8091,416.4281,408.528
EBITDA Ratio 0.190.1880.2070.1890.1310.1720.1810.1740.190.2540.2460.2440.2350.1990.1870.210.211